Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients

Archives of Disease in Childhood

Volumn 87, Issue 2, 2002, Pages 139-144

  Van der Kamp, H J ^a   Otten, B J ^b   Buitenweg, N ^a   De Muinck Keizer Schrama, S M P F ^c   Oostdijk, W ^a   Jansen, M ^d   Delemarre de Waal, H A ^e   Vulsma, T ^f   Wit, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDROCORTISONE ACETATE; GLUCOCORTICOID; HYDROCORTISONE; STEROID 21 MONOOXYGENASE;

ARTICLE; BODY HEIGHT; BODY MASS; BONE AGE; CHILD GROWTH; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GROWTH RETARDATION; HUMAN; MALE; NEWBORN SCREENING; PRIORITY JOURNAL; PROGNOSIS; PUBERTY; SALT LOSING NEPHRITIS; SODIUM DEPLETION; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADRENAL HYPERPLASIA, CONGENITAL; ANTI-INFLAMMATORY AGENTS; BODY HEIGHT; BODY MASS INDEX; BONE DEVELOPMENT; FEMALE; FLUDROCORTISONE; GROWTH; HUMANS; HYDROCORTISONE; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; PUBERTY; RETROSPECTIVE STUDIES;

EID: 0036318930     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.87.2.139     Document Type: Article

References (37)

1. Congenital adrenal hyperplasia
2. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data
3. Growth and final height in classical and nonclassical 21-hydroxylase deficiency
4. Growth of patients with 21-hydroxylase deficiency: An analysis of the factors influencing adult height
5. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): Relation to body mass index in earlier childhood
6. Evaluation of young women with congenital adrenal hyperplasia: A pilot study
7. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency
8. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens
9. Continuing positive secular growth change in the Netherlands 1955-1997
10. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty
11. The measurement of skeletal and dental maturity
12. Body index measurements in 1996-7 compared with 1980
13. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenal cortical hormones
14. 17-Hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia
15. Analysis of the adolescent growth spurt using smoothing spline functions
16. Somatic puberty development in girls
17. Patterns of growth from birth to maturity in infants and children with congenital adrenal hyperplasia
18. Early growth is not increased in untreated moderately severe 21-hydroxylase deficiency
19. Plasma renin activity as a marker for growth failure due to sodium deficiency in young rats
20. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia
21. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency
22. Plasma renin activity and the response to sodium depletion in salt-losing congenital adrenal hyperplasia
23. Mineralocorticoids
24. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth
25. The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency
26. Growth rate in infants with impaired renal function
27. Impact of sex steroids and their suppression on skeletal growth and maturation
28. Variations in duration of pubertal growth: A mechanism compensating for differences in timing of puberty and minimizing their effects on final height
29. An analysis of the mid-growth and adolescent spurts of height based on acceleration
30. The adolescent growth spurt of boys and girls of the Harpenden growth study
31. Serum osteocalcin and insulin-like growth factor I levels in children with congenital adrenal hyperplasia
32. Obesity in 21-hydroxylase deficient patients
33. Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy
34. Cortisol production rate in childhood and adolescence
35. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry